Paul is a versatile toxicologist within the pharmaceutical arena and has all round knowledge of all processes involved in drug research and development.  He is recognised internationally as an expert in the field of inhalation toxicology/aerosol science.  He has 30+ years experience in both CRO and pharmaceutical industries (AstraZeneca) as a study director/study monitor on a range of studies including all delivery routes and species but specialising as an inhalation toxicologist.  For the last 10 years at AstraZeneca Paul globally led the strategic implementation of preclinical outsourcing of inhalation toxicology studies, being accountable for all external work.  Paul has been an active committee member of the “Association of Inhalation Toxicologists” since 1987, organising the annual conference and working with regulators to improve the science of inhalation toxicology.